Skip to main content

Find Clinical Trials

Home
Conditions
Graft vs Host Disease

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

471 public trials 73 recruiting studies

Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Completed

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

NCT00003661

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +54 more
Locations: University of Florida Health Science Center Gainesville, Florida, United States

Division of Pediatric Surgery Jacksonville, Florida, United States

Nemours Children's Clinic Jacksonville, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View all 17 locations

View Trial Details

Completed

Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation

NCT00130754

Conditions: Graft vs Host Disease, Immune System Diseases, Stem Cell Transplantation
Locations: Hadassah Medical Organization Jerusalem, Israel

View Trial Details

Completed

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

NCT00361049

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +84 more
Locations: Geauga Regional Hospital Cleveland, Ohio, United States

Lake/University Ireland Cancer Center Cleveland, Ohio, United States

Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

University Suburban Health Center Cleveland, Ohio, United States

View Trial Details

Completed

Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer

NCT00248430

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: Seattle Cancer Care Alliance Seattle, Washington, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

NCT00357084

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +100 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Campath-1H + FK506 and Methylprednisolone for GVHD

NCT00109993

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Mt. Sinai Medical Center New York, United States

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Oregon Health Sciences University Portland, Oregon, United States

View Trial Details

Completed

Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder

NCT00054340

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +31 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

NCT00410657

Conditions: Aberrant Motor Behavior in Dementia, Adnexal Diseases, Aggression, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

NCT00346359

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +32 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

NCT00096096

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +76 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details